Disclosure of interest: Nothing to disclosure E-Posters - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P2594 - ESOC25-2450 CONSEQUENCE OF EARLY AND LATE THROMBOLYSIS FOLLOWING ISCHEMIC STROKE ON BRAIN METABOLIC PROFILES EVALUATED BY 9.4 T MR SPECTROSCOPY Henrik Andersson 1 , Kajsa Arkelius 1 , Michael Gottschalk 1 , Saema Ansar 1 1 Lund University, Lund, Sweden Background and Aims: Ischemic stroke is a significant contributor to mortality and disability worldwide
Check pH to assure proper dosage level
Zhang, B., Li, X., Tang, K., Xin, Y., Hu, G., Zheng, Y., et al
But the cause isnt clear
So interesting, esp since theyre also going after grandfathered medicines (pre-dating FDA existence)